📰 Johnw Umstead News

Johnw Umstead News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Johnw Umstead. Real-time updates on events, politics, business and more.

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights

May 1, 2024

01.05.2024 - - Achieved $14.1 Million in Net Revenue from Sales of COSELA (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results from Phase 2 Trial of Trilaciclib ...

Jack Bailey Johnw Umstead Drug Administration On Pepper Bio Inc Investor Relations Corporate Communications Therapeutics Inc

Source: wallstreet-online.de

G1 Therapeutics Provides Third Quarter 2023 Financial

November 1, 2023

G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights ...

United States Jack Bailey Sacituzumab Govitecan Hziy Johnw Umstead Research Triangle Park American Society Of Clinical Oncology

Source: globenewswire.com

G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights

May 3, 2023

- Drove 18% Quarterly Net Revenue Growth of COSELA® Over the Fourth Quarter of 2022; Grew Quarterly Vial Volume by 21% Over Prior Quarter - - Provided Updated Timing for Interim Overall Survival... | May 3, 2023

United States Jack Bailey Johnw Umstead Wedbush Pacgrow Sacituzumab Govitecan Hziy Raymond James

Source: marketscreener.com

G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

March 1, 2023

01.03.2023 - - Achieved $31.3 Million in Net Revenue from Sales of COSELA (trilaciclib) for Full Year 2022, Representing 182% Growth Over 2021; Provided 2023 Net COSELA Revenue Guidance of $50 to $60 Million - - Announced Top Line Results from Pivotal Phase 3 ...

Wedbush Pacgrow Johnw Umstead Raymond James Jen Moses Jack Bailey Society For Immunotherapy Of Cancer